Skip to main content
SpringerLink
Log in

Chromobacterium violaceum and its important metabolites — review

  • Review
  • Published:
Folia Microbiologica Aims and scope Submit manuscript

Abstract

C. violaceum appeared as important bacterium in different applications and mainly these aspects are related to the production of violacein. This review discusses the last reports on biosynthetic pathways, production, genetic aspects, biological activities, pathological effects, antipathogenic screening through quorum sensing, environmental effects and the products of C. violaceum with industrial interest. An important discussion is on biological applications in medicine and as industrial products such as textile and in cosmetics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CRC:

colorectal cancer

FDA:

Food and Drug Administration (FDA or USFDA), an agency of the United States Department of Health and Human Services

5-FU:

5-fluorouracil

QS:

quorum sensing

VIO:

violacein

References

  • Ahmetagic A., Pemberton J.M.: Stable high level expression of the violacein indolocarbazole anti-tumour gene cluster and the Streptomyces lividans amyA gene in E. coli K12. Plasmid63, 79–85 (2010).

    Article  CAS  PubMed  Google Scholar 

  • Ajithdoss D.K., Porter B.F., Calise D.V., Libal M.C., Edwards J.F.: Septicemia in a neonatal calf associated with Chromobacterium violaceum. Veter.Pathol.46, 71–74 (2009).

    Article  CAS  Google Scholar 

  • Al-Hussaini R., Mahasneh A.M.: Microbial growth and quorum sensing antagonist activities of herbal plants extracts. Molecules14, 3425–3435 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Alves O.L., Gimenez I.F., DE Azevedo M.M.M., Durán N., Melo P.S.: Phamacological use of cyclodextrine-Au-thiol-derivative/hydrophobic compound nanoparticles as antitumoral, antibacterial, antiviral and/or antiparasites, its obtention process and formulation. Brazil.Pat. PIBr 0502657-1 (2005).

    Google Scholar 

  • Anah M.U., Udo J.J., Ochigbo S.O., Abia-Bassey L.N.: Neonatal septicemia in calabar, Nigeria. Tropical Doctor38, 126–128 (2008).

    Article  CAS  PubMed  Google Scholar 

  • Andrighetti-frohner C.R., Kratz J.M., Antonio R.V., Creczynski-pasa T.B., Barardi C.R.M., Simoes C.M.O.: In vitro testing for genotoxicity of violacein assessed by Comet and Micronucleus assays. Mutat.Res.603, 97–103 (2006).

    PubMed  Google Scholar 

  • Antônio R.V., Creczynski-Pasa T.B.: Genetic analysis of violacein biosynthesis by Chromobacterium violaceum. Genet.Mol.Res.3, 85–91 (2004).

    PubMed  Google Scholar 

  • Antonisamy P., Kannan P., Ignacimuthu S.: Anti-diarrheal and ulcer-protective effects of violacein isolated from Chromobacterium violaceum in Wistar rats. Fundam.Clin.Pharmacol.23, 483–490 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Aoki S., Nomura T.: Violacein-containing natural bactericides, their manufacture, and cosmetics containing them. Japan Pat. JP 10139612 (1998).

  • Asamizu S., Kato Y., Igarashia Y., Onaka H.: VioE, a prodeoxyviolacein synthase involved in violacein biosynthesis, is responsible for intramolecular indole rearrangement. Tetrahedron Lett.48, 2923–2926 (2007).

    Article  CAS  Google Scholar 

  • Baek S.H., Kang H.S., Jang I.H., Lee J.S., Kim S.Y., Baek J.H., Kang J.G., Ahn J.M.: Insecticide and fungicide containing violacein, and their preparation method. Republ.Korean Pat. KR 20070 88150 A (2007).

  • Baker S., Campbell J.I., Stabler R., Nguyen H.V.M., To D.S., Nguyen D.V., Farrar J.: Fatal wound infection caused by Chromobacterium violaceum in Ho Chi Minh City, Vietnam. J.Clin.Microbiol.46, 3853–3855 (2008).

    Article  PubMed  Google Scholar 

  • Baldi M., Morales J.A., Hernandez G., Jimenez M., Alfaro A., Arquero-calvo e.: Chromobacterium violaceuminfection in a free-ranging Howler monkey in Costa Rica. J. Wildlife Dis.46, 306–310 (2010).

    Google Scholar 

  • Balibar C.J., Walsh C.T.: In vitro biosynthesis of violacein from L-tryptophan by the enzymes VioA-E from Chromobacterium violaceum. Biochemistry45, 15444–15457 (2006).

    Article  CAS  PubMed  Google Scholar 

  • Barreto E.S., Torres A.R., Barreto M.R., Vasconcelos A.T.R., Astolfi-filho S., Hungria M.: Diversity in antifungal activity of strains of Chromobacterium violaceum from the Brazilian Amazon. J.Ind.Microbiol.Biotechnol.35, 783–790 (2008).

    Article  CAS  PubMed  Google Scholar 

  • Becker M.H., Brucker R.M., Schwantes C.R., Harris R.N., Minbiole K.P.C.: The bacterially produced metabolite violacein is associated with survival of amphibians infected with a lethal fungus. Appl.Environ.Microbiol.75, 6635–6638 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Bodini S.F., Manfredini S., Epp M., Valentini S., Santori F.: Quorum sensing inhibition activity of garlic extract and p-coumaric acid. Lett.Appl.Microbiol.49, 551–555 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Bosch F.J., Badenhorst L., Le Roux J.A., Louw V.J.: Successful treatment of Chromobacterium violacelum sepsis in South Africa. J.Med.Microbiol.57, 1293–1295 (2008).

    Article  CAS  PubMed  Google Scholar 

  • Bosgelmez-Tinaz G., Ulusoy S., Ugur A., Ceylan O.: Inhibition of quorum sensing-regulated behaviors by Scorzonera sandrasica. Curr.Microbiol.55, 114–118 (2007).

    Article  CAS  PubMed  Google Scholar 

  • Bowers A.A., Greshock T.J., West N., Schreiber S.L., Wiest O., Williams R.M., Bradner J.E.: Synthesis and conformation-activity relationships of the peptide isosters of FK228 and largazole. J.Am.Chem.Soc.131, 2901–2905 (2009).

    Article  Google Scholar 

  • Brandl H., Lehmann S., Faramarzi M.A., Martinelli D.: Biomobilization of silver, gold, and platinum from solid waste materials by HCN-forming microorganisms. Hydrometallurgy94, 14–17 (2008).

    Article  CAS  Google Scholar 

  • Brown A.G.: Discovery and development of new β-lactam antibiotics. Pure Appl.Chem.59, 475–484 (1987).

    Article  CAS  Google Scholar 

  • Brucker R.M., Harris R.N., Schwantes C.R., Gallaher T.N., Flaherty D.C., Lam B.A., Minbiole K.P.C.: Amphibian chemical defense: antifungal metabolites of the microsymbiont Janthinobacterium lividum on the salamander Plethodon cinereus. J.Chem.Ecol.34, 1422–1429 (2008).

    Article  CAS  PubMed  Google Scholar 

  • Byrd L.C., Marcucci G., Parthun M.R., Xiao J.J., Klisovic R.B., Moran M., Lin T.S., Liu S., Sklenar A.R., Davis M.E., Lucas D.M., Fischer B., Shank R., Tejaswi S.L., Binkley P., Wright J., Chan K.K., Grever M.R.: A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia. Blood105, 959–967 (2005).

    Article  CAS  PubMed  Google Scholar 

  • Cao W., Chen W., Sun S., Guo P., Song J., Tian C., Cao W., Chen W., Sun S., Guo P., Song J., Tian C.: Investigating the antioxidant mechanism of violacein by density functional theory method. Investigating the antioxidant mechanism of violacein by density functional theory method. J.Mol.Struct.Theochem.817, 1–4 (2007).

    Article  CAS  Google Scholar 

  • Carminatti C.A., Oliveira I.L., Recouvreux D.O.S., Antonio R.V., Porto L.M.: Anthranilate synthase subunit organization in Chromobacterium violaceum. Genet.Mol.Res.7, 830–838 (2008).

    Article  CAS  PubMed  Google Scholar 

  • Carter E., Cain K., Rutland B.: Chromobacterium violaceum cellulitis and sepsis following cutaneous marine trauma. Cutis81, 269–272 (2008).

    PubMed  Google Scholar 

  • Chen C.N., Chen C.J., Liao C.T., Lee C.Y.: A probable aculeacin A acylase from the Ralstonia solanacearum GMI1000 is N-acylhomoserine-lactone acylase with quorum-quenching activity. BMC Microbiol.9, 89 doi:10.1186/1471-2180-9-89 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Cooper R., Unger S.: Novel potentiators of β-lactam antibiotics. Structures of SQ 28504 and SQ 28546. J.Org.Chem.51, 3942–3946 (1986).

    Article  CAS  Google Scholar 

  • Costa F.T.M., Justo G.Z., Duran N., Nogueira P.A., Lopes S.C.P.: Uso da violaceina na forma livre ouencapsulada em sistemas polimericos como antimalárico. Brazil.Pat. PIBr 056399-0 (2005).

  • de Azevedo M.B.M., Alderete J.B., Rodriguez J.A., DE Souza A.O., Rettori D., Torsoni M.A., Faljoni-alario A., Haun M., Durán N.: Biological activities of violacein: a new antitumoral indole derivative in an inclusion complex with β-cyclodextrin. J.Incl.Phenom.Macrocyclic Chem.37, 93–101 (2000a).

    Article  Google Scholar 

  • de Azevedo M.B.M., Melo P.S., Almeida A.B.A., Souza-brito A.R.M., Haun M., Durán N.: Antiulcerogenic activity of violacein/β-cyclodextrin inclusion complexes and violacein. Proc.Intern.Symp.Control.Rel.Bioact.Mater.27, 508–509 (2000b).

    Google Scholar 

  • de Carvalho D.D., Costa F.T.M., Durán N., Haun M.: Cytotoxic activity of violacein in human colon cancer cells. Toxicol. in Vitro20, 1514–1521 (2006).

    Article  PubMed  Google Scholar 

  • de Moss R.D.: Violacein. Antibiotics2, 77–81 (1967).

    Google Scholar 

  • Deines P., Matz C., Jurgens K.: Toxicity of violacein-producing bacteria fed to bacterivorous freshwater plankton. Limnol.Oceanogr.54, 1343–1352 (2009).

    Article  CAS  Google Scholar 

  • Dessaux Y., Elmerich C., Faure D.: Violacein: a molecule of biological interest originating from the soil-borne bacterium Chromobacterium violaceum. Rev.Med.Internat.25, 659–662 (2004).

    Article  CAS  Google Scholar 

  • Dobretsov S., Dahms H.U., Huang Yili H., Wahl M., Qian P.Y.: The effect of quorum-sensing blockers on the formation of marine microbial communities and larval attachment. FEMS Microbiol.Ecol.60, 177–188 (2007).

    Article  CAS  PubMed  Google Scholar 

  • Dufosse L.: Microbial production of food grade pigments. Food Technol.Biotechnol.44, 313–321 (2006).

    CAS  Google Scholar 

  • Durán N.: Violacein: an antibiotic discovery. Ciencia Hoje11, 58–80 (1990).

    Google Scholar 

  • Durán N., DE Azevedo M.M.M.: Compound incorporated in a polymeric nanoparticle with pharmaceutical or a cosmetic, its preparation process and cosmetic or pharmaceutical formulations. Brazil.Pat. PIBr 0404306-5 (2004).

  • Durán N., DE Souza A.O.: Process of violacein application as antimycobacterial compound. Brazil.Pat. PIBr 0101346-7 (2001).

    Google Scholar 

  • Durán N., Haun M.: Production, obtention and purification process and antitumoral activity of 3-[1,2-dihydro-5-(5-hydroxy-1H-indol-3-yl)-2-oxo-3H-pyrrol-3-ylidene]-1,3-dihydro-2H-indol-2-one. Brazil.Pat. PIBr 9702918 (1997).

  • Durán N., Menck C.F.M.: Chromobacterium violaceum: a review of farmacological and indutrial perspectives. Crit.Rev.Microbiol.27, 201–222 (2001).

    Article  PubMed  Google Scholar 

  • Durán N., Rettori D., Menck C.F.M.: Who is Chromobacterium violaceum? Biotecnol.Ciên.Desenvol.20, 38–43 (2001).

    Google Scholar 

  • Durán N., Justo G.Z., Melo P.S., DE Azevedo M.B.M., Souza-Brito A.R.M., Almeida A.B.A., Haun M.: Evaluation of the antiulcerogenic activity of violacein and its modulation by the inclusion complexation with β-cyclodextrin.Can.J.Physiol.Pharmacol.81, 387–396 (2003).

    Article  PubMed  Google Scholar 

  • Durán N., Justo G.Z., Melo P.S., Martins D. Jr., CORDI L.: Violacein: properties and biological activities. Biotechnol.Appl.Biochem.48, 127–133 (2007).

    Article  PubMed  Google Scholar 

  • Durán N., Marcato P.D., Alves O.L., DA Silva J.P.S., DE Souza G.I.H., Rodrigues F.A., Espósito E.: Ecosystem protection by effluent bioremediation: silver nanoparticles impregnation in a textile fabrics process. J.Nanopart.Res.12, 285–292 (2010).

    Article  Google Scholar 

  • Fairbrother L., Shapter J., Brugger J., Southam G., Pring A., Reith F.: Effect of the cyanide-producing bacterium Chromobacterium violaceum on ultraflat Au surfaces. Chem.Geol.265, 313–320 (2009).

    Article  CAS  Google Scholar 

  • Ferreira C.V., Bos C.L., Versreeg H.H., Justo G.Z., Durán N., Peppelenbosch M.P.: Molecular mechanism of violacein-mediated human promyelocytic leukemia cell-specific cytotoxicity. Blood104, 1459–1464 (2004).

    Article  CAS  PubMed  Google Scholar 

  • Gimenez I.F., Anazetti M.C., Melo P.S., Haun M., De Azevedo M.M.M., Durán N., Alves O.L.: Cytotoxicity on V79 and HL60 cell lines by thiolated-β-cyclodextrin-Au/violacein nanoparticles. J.Biomed.Nanotechnol.1, 352–358 (2005).

    Article  CAS  Google Scholar 

  • Gootz T.D.: Discovery and development of new antimicrobial agents. Clin.Microbiol.Rev.3, 13–31 (1990).

    CAS  PubMed  Google Scholar 

  • Gregory A., Ribollet D., Pailla K., Bourgade M., Alma S.: Chromobacterium violaceum septicemia: first case report in the French West Indies. Méd.Malad.Infect.37, 613–615 (2007).

    Article  CAS  Google Scholar 

  • Greshock T.J., Johns D.M., Noguchi Y., Williams R.M.: Improved total synthesis of the potent HDAC inhibitor FK228 (FR-901228). Org.Lett.10, 613–616 (2008).

    Article  CAS  PubMed  Google Scholar 

  • Guevara A., Salomon M., Oliveros M., Guevara E., Guevara M., Medina Z.: Sepsis caused by pigmented and no pigmented Chromobacterium violaceum. Rev.Chilena Infect.24, 402–406 (2007).

    Google Scholar 

  • Gupta R., Shah P., Swiatlo E.: Differential gene expression in Streptococcus pneumoniae in response to various iron sources. Microb.Pathogen.47, 101–109 (2009).

    Article  CAS  Google Scholar 

  • Hakvag S., Fjaervik E., Klinkenberg G., Borgos S.E.F., Josefsen K.D., Ellingsen T.E., Zotchev S.B.: Violacein-producing Collimonas sp. from the sea surface microlayer of costal waters in Trondelag, Norway. Marine Drugs7, 576–588 (2009).

    Article  PubMed  Google Scholar 

  • Harris R.N., Brucker R.M., Walke J.B., Becker M.H., Schwantes C.R., Flaherty D.C., Lam B.A., Woodhams D.C., Briggs C.J., Vredenburg V.T., Minbiole K.P.C.: Skin microbes on frogs prevent morbidity and mortality caused by a lethal skin fungus. ISME J.3, 818–824 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Haun M., Pereira M.F., Hoffman M.F., Riveros R., Joyas A., Campos V., Durán N.: Bacterial chemistry — VI. Biological activities and cyto-toxicity of 1,3-dihydro-2H-indol-2-one derivatives. Biol.Res.25, 21 (1992).

    CAS  PubMed  Google Scholar 

  • Hirano S., Asamizu S., Onaka H., Shiro Y., Nagano S.: Crystal structure of VioE, a key player in the construction of the molecular skeleton of violacein. J.Biol.Chem.283, 6459–6466 (2008).

    Article  CAS  PubMed  Google Scholar 

  • Kato H., Hata T., Shirata A., Tsukamoto T.: Improvement of lightfastness of fibers or fiber products dyed with violacein or deoxyviolacein bluish purple dyes by treating the dyed fibers with thiourea. Japan Pat. JP 1115 2687 A (1999).

  • Khan M.S.A., Zahin M., Hasan S., Husain F.M., Ahmad I.: Inhibition of quorum sensing regulated bacterial functions by plant essential oils with special reference to clove oil. Lett.Appl.Microbiol.49, 354–360 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Kita Y., Nishikawa H., Ike M., Takemoto T.: Enhancement of Au dissolution by microorganisms using an accelerating cathode reaction. Metallurg.Mat.Trans.B40B, 2009–2044 (2009).

    Google Scholar 

  • Kodach L.L., Bos C.L., Durán N., Peppelenbosh M.P., Ferreira C.V., Hardwick J.C.H.: Inhibition of Akt-mediated signal transduction in human colorectal cancer cells by violacein abrogates 5-fluorouracil chemoresistance. Carcinogenesis27, 508–516 (2006).

    Article  CAS  PubMed  Google Scholar 

  • Konzen M., DE Marco D., Cordova C.A.S., Vieira T.O., Antonio R.V., Creczynski-Pasa T.B.: Antioxidant properties of violacein: possible relation on its biological function. Bioorg.Med.Chem.14, 8307–8313 (2006).

    Article  CAS  PubMed  Google Scholar 

  • Kubo H., Kotani H., Yamamoto Y., Hazato T.: Involvement of sperm proteases in the binding of sperm to the vitelline envelope in Xenopus laevis. Zoolog.Sci.25, 80–87 (2008).

    Article  CAS  PubMed  Google Scholar 

  • Lai M.T., Yang C.C., Lin T.Y., Tsai F.J., Chen W.C.: Depsipeptide (FK228) inhibits growth of human prostate cancer cells. Urol. Oncol.Sem.Orig.Invest.26, 182–189 (2008).

    CAS  Google Scholar 

  • Leon L.L., Miranda C.C., De Souza A.O., Durán N.: Antileishmanial activity of the violacein extracted from Chromobacterium violaceum. J.Antimicrob.Chemother.48, 449–450 (2001).

    Article  CAS  PubMed  Google Scholar 

  • Lim I.W.M., Stride P.J., Horvath R.L., Hamilton-Craig C.R., Chau P.P.: Chromobacterium violaceum endocarditis and hepatic abscesses treated successfully with meropenem and ciprofloxacin. Med.J.Austral.190, 386–387 (2009).

    PubMed  Google Scholar 

  • Lima-Bittencourt C.I., Astolfi-Filho S., Chartone-Souza E., Santos F.R., Nascimento A.M.A.: Analysis of Chromobacterium sp. natural isolates from different Brazilian ecosystems. BMC Microbiol.7, 58 doi:10.1186/1471-2180-7-58 (2007).

    Article  PubMed  Google Scholar 

  • Lopes S.C.P., Blanco Y.C., Justo G.Z., Nogueira P.A., Rodrigues F.L.S., Goelnitz U., Wunderlich G., Facchini G., Brocchi M., Durán N., Costa F.T.M.: Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo. Antimocrob.Agents Chemother.53, 2149–2152 (2009).

    Article  CAS  Google Scholar 

  • Lu Y., Wang L., Xue Y., Zhang C., Xing X.H., Lou K., Zhang Z., Li Y., Zhang G., Bi J., Su Z.: Production of violet pigment by a newly isolated psychrotrophic bacterium from a glacier in Xinjiang, China. Biochem.Eng.J.43, 135–141 (2009).

    Article  CAS  Google Scholar 

  • Manjunath M.: Fatal septicemia due to Chromobacterium violaceum. West Indian Med.J.56, 380–381 (2007).

    CAS  PubMed  Google Scholar 

  • Martins D., Frungillo L., Anazzetti M.C., Melo P.S., Durán N.: Antitumoral activity of L-ascorbic acid-poly-d,l-(lactide-coglycolide) nanoparticles containing violacein. Internat.J.Nanomed.5, 77–85 (2010).

    Article  CAS  Google Scholar 

  • Masuoka Y., Shindoh N., Inamura N.: Histone deacetylase inhibitors from microorganisms: the Astellas experience, in F. Petersen, R. Amstutz: Natur.Comp.Drugs2, 335–359 (2008).

  • Matz C., Webb J.S., Schupp P.J., Phang S.Y., Penesyan A., Egan S., Steinberg P., Kjelleberg S.: Marine biofilm bacteria evade eukaryotic predation by targeted chemical defense. PLoS One3, e2744, doi:10.1371/journal.pone.0002744(2008).

    Article  PubMed  Google Scholar 

  • Meiring U., Lanzendoerfer G., Riedel H., Kallmayer V., Viala S., Mocigemba N., Schaefer J.: Cosmetic preparations containing violacein as dye. Ger.Pat. DE 102 005 051 869 A1 (2007).

  • Melo P.S., Justo G.Z., DE Azevedo M.B.M., Durán N., Haun M.: Violacein and its β-cyclodextrin complexes induce apoptosis and differentiation in HL60 cells. Toxicology186, 217–225 (2003).

    Article  CAS  PubMed  Google Scholar 

  • Melo P.S., DE Azevedo M.M.M., Frungillo L., Anazetti M.C., Marcato P.D., Durán N.: Nanocytotoxicity: violacein and violacein-loaded poly(d,l-lactide-co-glycolide) nanoparticles acting on human leukemic cells. J.Biomed.Nanotechnol.5, 192–201 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Mendes A.S., DE Carvalho J.E., Duarte M.C.T., Durán N., Bruns R.E.: Optimized production process of violacein and deoxyviolacein by Chromobacterium violaceum by factorial design and response surface methodology. Brazil.Pat. PIBr 0100199-0 (2001a).

  • Mendes A.S., DE Carvalho J.E., Duarte M.C.T., Durán N., Bruns R.E.: Factorial design and response surface optimization of crude violacein for Chromobacterium violaceum production. Biotechnol.Lett.23, 1963–1969 (2001b).

    Article  CAS  Google Scholar 

  • Morohoshi T., Kato M., Fukamachi K., Kato N., Ikeda T.: N-Acylhomoserine lactone regulates violacein production in Chromobacterium violaceum type strain ATCC 12472. FEMS Microbiol.Lett.279, 124–130 (2008).

    Article  CAS  PubMed  Google Scholar 

  • Nomura T.: Natural dye violacein manufacture with Chromobacterium and Janthinobacterium. Japan Pat. JP 0625 3864 A (1994).

  • Pantanella F., Berlutti F., Passariello C., Sarli S., Morea C., Schippa S.: Violacein and biofilm production in Janthinobacterium lividum. J.Appl.Microbiol.102, 992–999 (2007).

    CAS  PubMed  Google Scholar 

  • Pearson R.N.: Chromobacterium violaceum endocarditis and hepatic abscesses treated successfully with meropenem and ciprofloxacin. Med.J.Austral.191, 416 (2009).

    PubMed  Google Scholar 

  • Perpetuo E.A., Marques R.C.P., Mendes M.A., DE Lima W.C., Menck C.F.M., DO Nascimento C.A.O.: Characterization of the phenol monooxygenase gene from Chromobacterium violaceum: potential use for phenol biodegradation. Biotechnol.Bioproc. Eng.14, 694–701 (2009).

    Article  Google Scholar 

  • Pham V.A., Ting Y.P.: Gold bioleaching of electronic waste by cyanogenic bacteria and its enhancement with bio-oxidation. Adv.Mat. Res.71–73 (Biohydrometallurgy) 661–664 (2009).

    Article  Google Scholar 

  • Philip D.S., Sarovich D.S., Pemberton J.M.: pPSY: a vector for the stable cloning and expression of streptomycete single gene phenotypes in Escherichia coli. Plasmid60, 53–58 (2008).

    Article  CAS  PubMed  Google Scholar 

  • Philip D.S., Sarovich D.S., Pemberton J.M.: Complete sequence and analysis of the stability functions of pPSX, a vector that allows stable cloning and expression of streptomycete genes in Escherichia coli K12. Plasmid62, 39–43 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Praneenararat T., Geske G.D., Blackwell H.E.: Efficient synthesis and evaluation of quorum-sensing modulators using small molecule macroarrays. Org.Lett.11, 4600–4603 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Rettori D., Durán N.: Stationary tray bioreactor for the bacterial metabolite production. Brazil.Pat. PIBr 9702986-6 (1997).

  • Ryan K.S., Balibar C.J., Turo K.E., Walsh C.T., Drennan C.L.: The violacein biosynthetic enzyme VioE shares a fold with lipoprotein transporter proteins. J.Biol.Chem.283, 6467–6475 (2008).

    Article  CAS  PubMed  Google Scholar 

  • Sanchez C., Braña A.F., Mendez C., Salas J.A.: Reevaluation of the violacein biosynthetic pathway and its relationship to indolocarbazole biosynthesis. ChemBioChem.7, 1231–1240 (2006).

    Article  CAS  PubMed  Google Scholar 

  • Sarovich D.S., Pemberton J.M.: pPSX: a novel vector for the cloning and heterologous expression of antitumor antibiotic gene clusters. Plasmid57, 306–313 (2007).

    Article  CAS  PubMed  Google Scholar 

  • Shinoda K., Hasegawa T., Sato H., Shinozaki M., Kuramoto H., Takamiya Y., Sato T., Nikaidou N., Watanabe T., Hoshino T.: Biosynthesis of violacein: a genuine intermediate, protoviolaceinic acid, produced by VioABDE, and insight into VioC function. Chem.Commun. 4140–4142 (2007).

  • Shirata A., Tsukamoto T., Yasui H., Kato H., Hayasaka S., Kojima A.: Production of bluish-purple pigments by Janthinobacterium lividum isolated from the raw silk and dyeing with them. Nippon Sanshigaku Zasshi66, 377–385 (1997).

    CAS  Google Scholar 

  • Shirata A., Tsukamoto T., Kato H., Hata T., Yasui T., Kojima A.: Blue purple pigment manufacture with microorganism and applications of the pigment. Japan Kokai Tokkyo Koho JP 10113169 A (1998).

  • Shukla S.R., Damle A.J.: Colorants from microorganisms. Asian Dyer4, 33–34, 36–38 (2007).

    CAS  Google Scholar 

  • Singh B.N., Singh B.R., Singh R.L., Prakash D., Dhakarey R., Upadhyay G., Singh H.B.: Oxidative DNA damage protective activity, antioxidant and anti-quorum sensing potentials of Moringa oleifera. Food Chem.Toxicol.47, 1109–1116 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Slesak G., Douangdala P., Inthalad S., Silisouk J., Vongsouvath M., Sengduangphachanh A., Moore C.E., Mayxay M., Matsuoka H., Newton P.N.: Fatal Chromobacterium violaceum septicaemia in northern Laos, a modified oxidase test and post-mortem forensic family G6PD analysis. Ann.Clin.Microbiol.Antimicrob.8, 24 doi:10.1186/1476-0711-8-24 (2009).

    Article  PubMed  Google Scholar 

  • Swem L.R., Swem D.L., O’Loughlin C.T., Gatmaitan R., Zhao B., Ulrich S.M., Bassler B.L.: A quorum-sensing antagonist targets both membrane-bound and cytoplasmic receptors and controls bacterial pathogenicity. Mol.Cell35, 143–153 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Tan T.L., Montforts F.P., Meyer D.: Microbiological method for the biosynthesis of natural blue-violet colorants violacein and desoxyviolacein. PCT Internat.Appl. WO 20020 50299 A2 (2002).

  • Teasdale M.E., Liu J.Y., Wallace J., Akhlaghi F., Rowley D.C.: Secondary metabolites produced by the marine bacterium Halobacillus salinus that inhibit quorum sensing-controlled phenotypes in Gram-negative bacteria. Appl.Environ.Microbiol.75, 567–572 (2009).

    Article  CAS  PubMed  Google Scholar 

  • Uroz S., Oger P., Chhabra S.R., Cámara M., Williams P., Dessaux Y.: N-Acylhomoserine lactones are degraded via an amidolytic activity in Comamonas sp. strain D1. Arch.Microbiol.187, 249–256 (2007).

    Article  CAS  PubMed  Google Scholar 

  • Vasconcelos A.T.R.et al. (Brazilian National Genome Project Consortium; 109 authors): The complete genome of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability. Proc.Nat.Acad.Sci.USA100, 11660–11665 (2003).

    Article  Google Scholar 

  • Vattem D.A., Mihalik K., Crixell S.H., Mclean R.J.C.: Dietary phytochemicals as quorum sensing inhibitors. Fitoterapia78, 302–310 (2007).

    Article  CAS  PubMed  Google Scholar 

  • Vijayan A.P., Anand M.R., Remesh P.: Chromobacterium violaceum sepsis in an infant. Indian Pedriat.46, 721–722 (2009).

    CAS  Google Scholar 

  • Wang Y., Ikawa A., Okaue S., Taniguchi S., Osaka I., Yoshimoto A., Kishida Y., Arakawa R., Enomoto K.: Quorum sensing signaling molecules involved in the production of violacein by Pseudoalteromonas. Biosci.Biotechnol.Biochem.72, 1958–1961 (2008).

    Article  CAS  PubMed  Google Scholar 

  • Wang H., Jiang P., Lu Y., Ruan Z., Jiang R., Xin-hui Xing X.H., Lou K., Wei D.: Optimization of culture conditions for violacein production by a new strain of Duganella sp. B2. Biochem.Eng.J.44, 119–124 (2009).

    Article  CAS  Google Scholar 

  • Watine J., Courtade A., Pham E., Lievrouw C., Dubourdieu B., Guerin B., Gineston J.L.: Chromobacterium violaceum peritonitis: case report and literature review. Ann.Biol.Clin.64, 327–330 (2006).

    CAS  Google Scholar 

  • Yada S., Wang Y., Zou Y., Nagasaki K., Hosokawa K., Osaka I., Arakawa R., Enomoto K.: Isolation and characterization of two groups of novel marine bacteria producing violacein. Marine Biotechnol.10, 128–132 (2008).

    Article  CAS  Google Scholar 

  • Yang L.H., Xiong H., Lee O.O., Qi S.H., Qian P.Y.: Effect of agitation on violacein production in Pseudoalteromonas luteoviolacea isolated from a marine sponge. Lett.Appl.Microbiol.44, 625–630 (2007).

    Article  CAS  PubMed  Google Scholar 

  • Yurek-george A., Cecil A.R.L., Mo A.H.K., Wen S., Rogers H., Habens F., Maeda S., Yoshida M., Packham G., Ganesan A.: The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor. J.Med.Chem.50, 5720–5726 (2007).

    Article  CAS  PubMed  Google Scholar 

  • Zhu H., Sun S.J.: Inhibition of bacterial quorum sensing-regulated behaviors by Tremella fuciformis extract. Curr.Microbiol.57, 418–422 (2008).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biological Chemistry Laboratory, Institute of Chemistry, Universidade Estadual de Campinas, C.P. 6254, CEP, 13083-970, Campinas, SP., Brazil

    M. Durán & N. Durán

  2. Department of Biochemistry and Biophysic, Center of Natural and Human Sciences, Universidade Federal do ABC, CEP 09.210-170, Santo André, SP., Brazil

    A. Faljoni-Alario & N. Durán

Authors
  1. M. Durán
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Faljoni-Alario
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Durán
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Durán, M., Faljoni-Alario, A. & Durán, N. Chromobacterium violaceum and its important metabolites — review. Folia Microbiol 55, 535–547 (2010). https://doi.org/10.1007/s12223-010-0088-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12223-010-0088-4

Keywords

Search

Navigation